StockData
VivoSim Labs, INC. logo

VivoSim Labs, INC. (VIVS) stock

VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.12−0.00 (-0.08%)

Close on Nov 18, 2026Market cap $383.32KP/E –Yield –

VivoSim Labs price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

VivoSim Labs's price to book ratio was 0.8× on Apr 30, 2026, against 7.6× a year earlier. Over the last 5 years it ranged from 0.3× to 30.6×, with a median of 1.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20260.8×+0.2
2025Dec 31, 20250.7×−1.3
2024Dec 31, 20241.9×+0.8
2023Dec 29, 20231.1×+0.7
2022Dec 30, 20220.5×−0.4
2021Dec 31, 20210.9×−3.2
2020Dec 31, 20204.1×+2.6
2019Dec 31, 20191.5×−1.3
2018Dec 31, 20182.8×+0.1
2017Dec 29, 20172.8×−3.3
2016Dec 30, 20166.1×+3.0
2015Dec 31, 20153.0×−7.9
2014Dec 31, 201410.9×–

More VivoSim Labs figures

See a number that looks wrong?